Clinical Trial Update: Clinical Study in Treatment of Malignant Ascites of Ovarian Cancer With Intraperitoneal Injection Bevacizumab Combined With Intraperitoneal Hyperthermic Perfusion Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical study evaluating intraperitoneal bevacizumab combined with intraperitoneal hyperthermic perfusion chemotherapy for malignant ascites in ovari…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Ovarian Cancer With Malignant Ascites | Phase 2 | Status: UNKNOWN